NFA
AVXL icon

Nationwide Fund Advisors’s Anavex Life Sciences AVXL Stock Holding History

Nationwide Fund Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-18,498
Closed -$77K – 194
2017
Q3 		$77K Hold
18,498
– – ﹤0.01% 2976
2017
Q2 		$98K Hold
18,498
– – ﹤0.01% 2903
2017
Q1 		$106K Sell
18,498
-2,779
-13% -$14.4K ﹤0.01% 2819
2016
Q4 		$84K Hold
21,277
– – ﹤0.01% 2917
2016
Q3 		$77K Hold
21,277
– – ﹤0.01% 2971
2016
Q2 		$130K Buy
+21,277
New +$103K ﹤0.01% 2811

Other funds holding AVXL

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nationwide Fund Advisors's AVXL Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Anavex Life Sciences (AVXL) in Q4 2017, closing a stake of 18,498 shares — an estimated $77K sold.

Nationwide Fund Advisors first reported a position in AVXL in Q2 2016 and held it in 6 quarters. The position peaked at $130K in Q2 2016. 65 funds tracked by Wall St. Rank hold AVXL as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Anavex Life Sciences position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 18,498 Anavex Life Sciences shares in Q4 2017, an estimated $77K.
  • Nationwide Fund Advisors first reported a position in Anavex Life Sciences in Q2 2016 and held it in 6 quarters.
  • Nationwide Fund Advisors's Anavex Life Sciences position peaked at $130K in Q2 2016.
  • 65 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.